Could bank loans solve Europe's biotech financing slump?

Article Abstract:

The giant European Investment Bank (EIB) is planning to loan millions of euros to biotech firms in late-stage product development to improve the Europe's weak financing record. The EIB initiative comes in response to pressure from the European Commission, which has identified a 'financing gap'-particularly in the late stage as the biggest single barrier to European Union biotech competitiveness.

Europe, Strategy & planning, Contracts & orders received, Contracts & orders let, Planning, Contracts, Contract agreement, Company business planning, European Union. European Investment Bank

---

Power dating: A guide to VC courtship

Article Abstract:

Biotech firms who wish to collaborate with Venture Capital firms for financing, should concentrate on good planning and on the ability to read between the lines, negligence of both of which may lead to failure of their collaborations. Several examples of failures that could sink even the most promising of courtships with a Venture capital firm are presented.

United States, Venture Capital Companies, Miscellaneous Intermediation, Investors, not elsewhere classified, Methods, Company investment, Investments, Investment management

---

Similar abstracts:

• Abstracts: The changing attitude of European VCs. Next-generation monoclonals less profitable than trailblazers?
• Abstracts: Effect of carpal tunnel syndrome on grip force coordination on hand tools. The development of risk assessment models for carpal tunnel syndrome: a case-referent study
• Abstracts: Reexamining the research exemption. Negotiating the RNAi patent thicket. US courts struggle with new patent infringement standards
• Abstracts: Chimeras in the crosshairs7. Boutiques reborn in 2003

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.